RT Journal Article SR Electronic T1 Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available JF Cleveland Clinic Journal of Medicine JO Cleve Clin J Med FD Cleveland Clinic SP 760 OP 766 DO 10.3949/ccjm.85a.17108 VO 85 IS 10 A1 Anna Camille Moreno A1 Sabrina K. Sikka A1 Holly L. Thacker YR 2018 UL http://www.ccjm.org/content/85/10/760.abstract AB When treating the genitourinary syndrome of menopause (GSM) in women with breast cancer or at high risk of breast cancer, clinicians must balance the higher cancer risks associated with hormonal treatments against the severity of GSM symptoms, which can be exacerbated by breast cancer treatments. Options for patients who need hormonal therapy include locally applied estrogens, dehydroepiandrosterone (DHEA), and estrogen receptor agonists/antagonists, which vary in their impact on breast cancer risk.